Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 9;160(11):495-498.
doi: 10.1016/j.medcli.2023.01.012. Epub 2023 Jan 30.

Staphylococcus aureus bacteremia in patients with SARS-CoV-2 infection

[Article in English, Spanish]
Iker Falces-Romero  1 , Iván Bloise  2 , Julio García-Rodríguez  3 , Emilio Cendejas-Bueno  3 ; SARS-CoV-2 Working Group
Collaborators, Affiliations

Staphylococcus aureus bacteremia in patients with SARS-CoV-2 infection

[Article in English, Spanish]
Iker Falces-Romero et al. Med Clin (Barc). .

Abstract
in English, Spanish

Objectives: The aim was to compare the incidence of Staphylococcus aureus bacteremia in COVID-19 and non-COVID-19 adult patients during the pandemic period versus the previous two years. Also, we described the characteristics of both cohorts of patients in pandemic period to find differences.

Material and methods: Retrospective study in our tertiary-care centre reviewing S. aureus bacteremia episodes in COVID-19 and non-COVID-19 patients through clinical records and the Microbiology Department database.

Results: In 2018 and 2019, the incidence of S. aureus bacteremia episodes was 1.95 and 1.63 per 1000 admissions respectively. In the pandemic period, global incidence was 1.96 episodes per 1000 non-COVID-19 admissions and 10.59 episodes per 1000 COVID-19 admissions. A total of 241 bacteremia was registered during this pandemic period in 74 COVID-19 patients and in 167 non-COVID-19 patients. Methicillin resistance was detected in 32.4% and 13.8% of isolates from COVID-19 and non-COVID-19 patients respectively. In COVID-19 patients, mortality rates were significantly higher.

Conclusions: We showed a significantly high rates of S. aureus bacteremia incidence in COVID-19 patients and higher methicillin resistance and 15-day mortality rates than in non-COVID-19 patients.

Objetivos: Comparar la incidencia de bacteriemias por Staphylococcus aureus en pacientes adultos COVID-19 y no-COVID-19 durante la pandemia frente a los 2 años previos. Además, describimos las características de ambas cohortes en periodo pandémico para encontrar diferencias.

Material y métodos: Estudio retrospectivo en nuestro centro de tercer nivel a través de historias clínicas y la base de datos del Servicio de Microbiología.

Resultados: En 2018 y 2019, la incidencia de bacteriemias fue de 1.95 y 1,63 casos por cada 1.000 ingresos respectivamente. En pandemia, la incidencia global fue de 1,96 casos por cada 1.000 ingresos no-COVID-19 y de 10,59 casos por cada 1.000 ingresos COVID-19. Durante la pandemia se registraron 241 bacteriemias en 74 pacientes COVID-19 y en 167 pacientes no-COVID-19. La resistencia a meticilina se detectó en el 32,4 y 13,8% de los aislados de pacientes COVID-19 y no-COVID-19 respectivamente. En pacientes COVID-19 la mortalidad fue significativamente mayor.

Conclusiones: Mostramos una incidencia significativamente alta de bacteriemias por S. aureus en pacientes COVID-19, así como mayores tasas de resistencia a meticilina y mortalidad a los 15 días que en pacientes no-COVID-19.

Keywords: Bacteremia; Bacteriemia; COVID-19; SARS-CoV-2; Staphylococcus aureus.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Difference in survival probability among the two cohorts up to day 15 (A) and 30 (B).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Giacobbe D.R., Battaglini D., Ball L., Brunetti I., Bruzzone B., Codda G., et al. Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020;50:e13319. - PMC - PubMed
    1. Musuuza J.S., Watson L., Parmasad V., Putman-Buehler N., Christensen L., Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLOS ONE. 2021;16:e0251170. - PMC - PubMed
    1. Buehler P.K., Zinkernagel A.S., Hofmaenner D.A., Wendel Garcia P.D., Acevedo C.T., Gómez-Mejia A., et al. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Rep Med. 2021;2:100229. - PMC - PubMed
    1. Cusumano J.A., Dupper A.C., Malik Y., Gavioli E.M., Banga J., Caban A.B., et al. Staphylococcus aureus bacteremia in patients infected with COVID-19: a case series. Open Forum Infect Dis. 2020;7:ofaa518. - PMC - PubMed
    1. Didierlaurent A., Goulding J., Patel S., Snelgrove R., Low L., Bebien M., et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med. 2008;205:323–329. - PMC - PubMed

Publication types